momelotinib
momelotinib: sourced relationships with 1 company · 5 clinical trials tracked.
momelotinib evidence translation
What we can confirm
5 tracked trials
What it means
What to watch
Prepared research question
How could momelotinib → SRRA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 1 study sponsors
Study sponsors
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Sierra Oncology, Inc. (SRRA) | Phase 3 |
Clinical Trial Registry Records (5)
Phase Ib/II Study Of Revumenib As Monotherapy Or In Combination With Jak Inhibitors In Patients With Myelofibrosis
Primary endpoint: Dose limiting toxicity (DLT)
A Randomized Open Label Trial Comparing Momelotinib vs Dose-Adjusted Ruxolitinib For Treatment-Naive, Cytopenic Myelofibrosis
Primary endpoint: To estimate and compare the proportion of participants achieving a dual response [SVR35] and transfusion independence response from red blood cell transfusions.
A Pilot Study of Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia (M-HArbOr)
Primary endpoint: Number of participants who achieve a complete response
A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Primary endpoint: Proportion of Participants with Spleen Volume Reduction ≥35% (SVR35) at Week 24
A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-88549968, a T-cell Redirecting Bispecific Antibody for CALR-mutated Myeloproliferative Neoplasms
Primary endpoint: Part 1, Part 1b (US Only): Number of Participants With Dose Limiting Toxicity (DLT)
Frequently asked questions
Which companies have sourced relationships with momelotinib?
momelotinib has dated SEC/FDA relationship records for Sierra Oncology, Inc..
How many clinical trials involve momelotinib?
BioSniper tracks 5 clinical trials involving momelotinib.